MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy

Abstract Bioenergetic therapy based on tumor glucose metabolism is emerging as a promising therapeutic modality. To overcome the poor bioavailability and toxicity of arenobufagin (ArBu), a MOF-derived intelligent nanosystem, ZIAMH, was designed to facilitate energy deprivation by simultaneous interv...

Full description

Saved in:
Bibliographic Details
Main Authors: Lihua Chen, Jiaying Yang, Lingyu Jia, Xiaolu Wei, Huijun Wang, Zhuo Liu, Shan Jiang, Pengyue Li, Yanyan Zhou, Hongjie Wang, Nan Si, Baolin Bian, Qinghe Zhao, Haiyu Zhao
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-024-03084-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594405326848000
author Lihua Chen
Jiaying Yang
Lingyu Jia
Xiaolu Wei
Huijun Wang
Zhuo Liu
Shan Jiang
Pengyue Li
Yanyan Zhou
Hongjie Wang
Nan Si
Baolin Bian
Qinghe Zhao
Haiyu Zhao
author_facet Lihua Chen
Jiaying Yang
Lingyu Jia
Xiaolu Wei
Huijun Wang
Zhuo Liu
Shan Jiang
Pengyue Li
Yanyan Zhou
Hongjie Wang
Nan Si
Baolin Bian
Qinghe Zhao
Haiyu Zhao
author_sort Lihua Chen
collection DOAJ
description Abstract Bioenergetic therapy based on tumor glucose metabolism is emerging as a promising therapeutic modality. To overcome the poor bioavailability and toxicity of arenobufagin (ArBu), a MOF-derived intelligent nanosystem, ZIAMH, was designed to facilitate energy deprivation by simultaneous interventions of glycolysis, OXPHOS and TCA cycle. Herein, zeolitic imidazolate framework-8 was loaded with ArBu and indocyanine green, encapsulated within metal–phenolic networks for chemodynamic therapy and hyaluronic acid modification for tumor targeting. ZIAMH nanoparticles can release ArBu in the tumor microenvironment for chemtherapy, and ICG enables photothermal therapy under near-infrared laser irradiation. In vitro and in vivo mechanism studies revealed that the ZIAMH nanoplatform downregulated glucose metabolism related genes, resulting in the reduction of energy substances and metabolites in tumors. Additionally, it significantly promoted cell apoptosis by upregulating pro-apoptotic proteins such as Bax, Bax/Bcl-2, cytochrome C. Animal studies have shown that the tumor inhibition efficiency of ZIAMH nanomedicines was three fold higher than that of free drugs. Therefore, this study provides a new strategy for glucose metabolism-mediated bioenergetic therapy and PTT/CDT/CT combined therapy for tumors. Graphical Abstract
format Article
id doaj-art-51f1db58034f48518379a623a2a74e41
institution Kabale University
issn 1477-3155
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj-art-51f1db58034f48518379a623a2a74e412025-01-19T12:37:50ZengBMCJournal of Nanobiotechnology1477-31552025-01-0123111910.1186/s12951-024-03084-1MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapyLihua Chen0Jiaying Yang1Lingyu Jia2Xiaolu Wei3Huijun Wang4Zhuo Liu5Shan Jiang6Pengyue Li7Yanyan Zhou8Hongjie Wang9Nan Si10Baolin Bian11Qinghe Zhao12Haiyu Zhao13State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesKey Laboratory of Biomechanics and Mechanobiology of Ministry of Education, Advanced Innovation Center for Biomedical Engineering, School of Engineering Medicine, Beihang UniversityState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesState Key Laboratory for Quality Ensurance and Sustainable Use of Dao-Di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical SciencesAbstract Bioenergetic therapy based on tumor glucose metabolism is emerging as a promising therapeutic modality. To overcome the poor bioavailability and toxicity of arenobufagin (ArBu), a MOF-derived intelligent nanosystem, ZIAMH, was designed to facilitate energy deprivation by simultaneous interventions of glycolysis, OXPHOS and TCA cycle. Herein, zeolitic imidazolate framework-8 was loaded with ArBu and indocyanine green, encapsulated within metal–phenolic networks for chemodynamic therapy and hyaluronic acid modification for tumor targeting. ZIAMH nanoparticles can release ArBu in the tumor microenvironment for chemtherapy, and ICG enables photothermal therapy under near-infrared laser irradiation. In vitro and in vivo mechanism studies revealed that the ZIAMH nanoplatform downregulated glucose metabolism related genes, resulting in the reduction of energy substances and metabolites in tumors. Additionally, it significantly promoted cell apoptosis by upregulating pro-apoptotic proteins such as Bax, Bax/Bcl-2, cytochrome C. Animal studies have shown that the tumor inhibition efficiency of ZIAMH nanomedicines was three fold higher than that of free drugs. Therefore, this study provides a new strategy for glucose metabolism-mediated bioenergetic therapy and PTT/CDT/CT combined therapy for tumors. Graphical Abstracthttps://doi.org/10.1186/s12951-024-03084-1ArenobufaginNanomedicineGlycolysisOxidative phosphorylationTricarboxylic acid cycleBioenergetic therapy
spellingShingle Lihua Chen
Jiaying Yang
Lingyu Jia
Xiaolu Wei
Huijun Wang
Zhuo Liu
Shan Jiang
Pengyue Li
Yanyan Zhou
Hongjie Wang
Nan Si
Baolin Bian
Qinghe Zhao
Haiyu Zhao
MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
Journal of Nanobiotechnology
Arenobufagin
Nanomedicine
Glycolysis
Oxidative phosphorylation
Tricarboxylic acid cycle
Bioenergetic therapy
title MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
title_full MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
title_fullStr MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
title_full_unstemmed MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
title_short MOF-derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal-chemodynamic-chemotherapy
title_sort mof derived intelligent arenobufagin nanocomposites with glucose metabolism inhibition for enhanced bioenergetic therapy and integrated photothermal chemodynamic chemotherapy
topic Arenobufagin
Nanomedicine
Glycolysis
Oxidative phosphorylation
Tricarboxylic acid cycle
Bioenergetic therapy
url https://doi.org/10.1186/s12951-024-03084-1
work_keys_str_mv AT lihuachen mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT jiayingyang mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT lingyujia mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT xiaoluwei mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT huijunwang mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT zhuoliu mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT shanjiang mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT pengyueli mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT yanyanzhou mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT hongjiewang mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT nansi mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT baolinbian mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT qinghezhao mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy
AT haiyuzhao mofderivedintelligentarenobufaginnanocompositeswithglucosemetabolisminhibitionforenhancedbioenergetictherapyandintegratedphotothermalchemodynamicchemotherapy